Clinical trial
Prevention of Fetal Alcohol Damage Using Maternal Blood Markers
NCT00696085 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Fetal Alcohol Damage Using Maternal Blood Markers
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2004
- Completion date
- February 29, 2008
- Enrollment
- 612 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fetal alcohol syndrome, substance abuse